A two-participant pilot study of intravenous BPC-157

An independent summary of a 2025 single-center pilot safety study: what was measured across two adults and two infusions, what the investigators observed, and why the findings remain preliminary.

CJC-1295 DAC in healthy adults: two early-phase human trials

An independent summary of two randomized, placebo- controlled 2006 trials: prolonged GH and IGF-1 elevation, common non-serious adverse events, and the product- identity and follow-up limits on what the data can support.